SODIUM CHLORIDE - Generic Drug Details

What are the generic drug sources for sodium chloride and what is the scope of patent protection?

Sodium chloride is the generic ingredient in fourteen branded drugs marketed by Blairex, Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Miles, Otsuka Icu Medcl, Medefil Inc, Fresenius Medcl, Gvs Tm, Laboratorios Grifols, Liebel-flarsheim, Abraxis Pharm, Hikma, Nexus, Spectra Mdcl Devices, Icu Medical Inc, Jubilant Cadista, Nephron, and Taro, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for sodium chloride. Twenty-five suppliers are listed for this compound.

Summary for SODIUM CHLORIDE

US Patents:	0
Tradenames:	14
Applicants:	21
NDAs:	56
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	25
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	6,446
Drug Prices:	Drug price trends for SODIUM CHLORIDE
What excipients (inactive ingredients) are in SODIUM CHLORIDE?	SODIUM CHLORIDE excipients list
DailyMed Link:	SODIUM CHLORIDE at DailyMed

See drug prices for SODIUM CHLORIDE

See drug sales revenues for SODIUM CHLORIDE

Pharmacology for SODIUM CHLORIDE

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for SODIUM CHLORIDE

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for SODIUM CHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	SODIUM CHLORIDE 0.9%	sodium chloride	SOLUTION;INJECTION	201833-002	Jan 7, 2015	AP	RX	No	No
Gvs Tm	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	076316-001	Oct 27, 2004	AP	RX	No	No
Fresenius Kabi Usa	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	088912-004	Nov 29, 1985		RX	No	Yes
Otsuka Icu Medcl	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;IRRIGATION	018314-001	Approved Prior to Jan 1, 1982	AT	RX	No	No

Market Dynamics and Financial Trajectory for Sodium Chloride in Pharmaceuticals

Last updated: February 14, 2026

What Is the Current Market Size of Pharmaceutical Sodium Chloride?

Sodium chloride (NaCl) used in pharmaceutical applications primarily functions as a rehydration solution, diluent, or preservative. The global pharmaceutical-grade sodium chloride market was valued at approximately $1.2 billion in 2022 and is projected to reach $1.6 billion by 2030, expanding at a CAGR of 4.2%. The growth is driven by increased demand for infusion therapies, especially in hospitals and outpatient settings.

How Does Market Demand Evolve with Healthcare Trends?

Demand growth correlates with several factors:

• Rising incidence of dehydration and electrolyte imbalances: Conditions such as diarrhea, vomiting, and chronic illnesses increase infusion therapy needs, boosting sodium chloride utilization.
• Growth in intravenous therapy procedures: Hospitals increasingly adopt infusion therapies, especially during COVID-19, accelerating sodium chloride usage.
• Expanding pharmaceutical formulations: As novel drug delivery methods evolve, sodium chloride's role as a diluent remains stable.

What Are Major Market Segments and Their Dynamics?

Market segmentation focuses on form, application, and end-user:

Segment	Market Share (2022)	Growth Drivers
Formulation Type	Solution (98%), Powder (2%)	Solutions are used in IV infusions; powder used in compounding
Application	Parenteral (85%), Oral (10%), Others (5%)	Parenteral solutions dominate due to direct bloodstream delivery
End-User	Hospitals (60%), Clinics (25%), Pharmaceutical manufacturers (10%), Research labs (5%)	Hospitals prioritizing infusion therapies

What Are Key Market Drivers and Challenges?

Drivers:

• Growth in healthcare infrastructure across emerging markets.
• Aging populations increase chronic disease management.
• Stable supply chain for pharmaceutical-grade sodium chloride.

Challenges:

• Price volatility due to raw material supply fluctuations.
• Stringent quality and safety regulations.
• Competition from alternative electrolytes (e.g., potassium chloride).

Which Key Companies Dominate the Market?

Leading producers include:

• BASF SE: Supplies pharmaceutical-grade sodium chloride with extensive distribution channels.
• Tata Chemicals Ltd.: Focuses on high-purity sodium chloride for medical applications.
• PQ Corporation: Provides pharmaceutical-specific formulations of sodium chloride.
• Thermo Fisher Scientific: Supplies sodium chloride for research, manufacturing, and clinical use.

Market concentration remains moderate, with the top three players controlling approximately 65% of the market.

What Is the Financial Outlook for Sodium Chloride in Pharmaceuticals?

Financial growth remains steady, supported by the non-cyclic nature of healthcare demand. Revenue streams are largely recurring, driven by hospital procurement contracts. Raw material prices influence margins; however, large manufacturers have leverage through supply chain efficiencies.

Expected revenue growth rate for pharmaceutical-grade sodium chloride is approximately 4.2%, aligning with overall healthcare infrastructure expansion. Margins hover around 15-20%, with economies of scale in manufacturing playing a crucial role.

How Do Regulatory Policies Affect Market Trajectory?

Regulatory agencies like the FDA and EMA mandate strict guidelines on reagent purity and sterility. Recent updates favor high-purity grades (USP, EP), which require advanced manufacturing and quality assurance processes, increasing compliance costs but ensuring market stability.

New regulations in emerging markets aim to harmonize standards, potentially opening new markets for established producers. Conversely, non-compliance risks include product recalls and bans, impacting financial stability.

What Are Emerging Trends Influencing Future Growth?

• Bio-pharmaceutical integration: Sodium chloride increasingly used in biologic drug formulations.
• Sustainable manufacturing practices: Focus on reducing environmental impact.
• Technological innovations: Microfluidics and automation improve formulation precision and supply chain efficiency.

How Is Competition Shaping for Long-Term Market Share?

The market features moderate competition with high barriers to entry due to regulatory requirements and the need for specialized manufacturing facilities. Price competition centers on purity, supply reliability, and logistics.

Large multinational companies maintain leadership through continuous quality improvements, capacity expansion, and strategic acquisitions. Smaller players often target niche markets or regional markets to gain footholds.

---

Key Takeaways

• The pharmaceutical sodium chloride market reached $1.2 billion in 2022 and is forecasted to grow at 4.2% annually through 2030.
• Demand is driven largely by IV therapies, with hospitals and clinics as primary end-users.
• Supply chain stability and regulatory compliance are critical to maintaining market position.
• Competition intensity is moderate, dominated by large global players.
• Registering new production capacity involves significant investment due to high regulatory standards.

---

FAQs

1. What is the primary use of sodium chloride in pharmaceuticals?
   It functions mainly as an intravenous infusion solution, diluent, or preservative.

2. Which regions are driving market growth?
   North America and Europe lead due to mature healthcare sectors, while Asia-Pacific exhibits rapid growth via expanding healthcare infrastructure.

3. Are alternative electrolytes reducing sodium chloride demand?
   Alternative electrolytes have niche applications, but sodium chloride remains dominant in infusion therapy due to cost-effectiveness and compatibility.

4. How do regulatory changes impact market players?
   Stricter standards increase manufacturing costs but reinforce market stability by ensuring product quality and safety.

5. What future innovations could influence this market?
   Integration with biologic formulations and advances in sustainable manufacturing are key future impacts.

Citations

[1] MarketWatch, "Pharmaceutical Sodium Chloride Market Size and Forecast," 2023.
[2] Grand View Research, "Electrolyte Solutions Market," 2022.
[3] IQVIA, "Global Pharmaceutical Market Trends," 2022.
[4] U.S. Food and Drug Administration, "Guidelines for sterile pharmaceuticals," 2022.